rebamipide mofetil (SA001) / Samjin Pharma - LARVOL DELTA

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome (clinicaltrials.gov) - P2a | N=28 | Completed | Sponsor: Samjin Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed

Trial completion • Dry Eye Disease • Ophthalmology • Sjogren's Syndrome • Xerostomia

Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers (clinicaltrials.gov) - P1 | N=56 | Completed | Sponsor: Samjin Pharmaceutical Co., Ltd.

New P1 trial

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers (clinicaltrials.gov) - P1 | N=40 | Completed | Sponsor: Samjin Pharmaceutical Co., Ltd. | Recruiting ➔ Completed | N=96 ➔ 40

Enrollment change • Trial completion

Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome. (clinicaltrials.gov) - P2 | N=172 | Completed | Sponsor: Samjin Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed

Trial completion • Dry Eye Disease • Ophthalmology

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome (clinicaltrials.gov) - P2a | N=28 | Active, not recruiting | Sponsor: Samjin Pharmaceutical Co., Ltd.

New P2a trial • Dry Eye Disease • Ophthalmology • Sjogren's Syndrome • Xerostomia